Mylin Biotech Pvt Ltd
Add Your Heading Text Here
Chronic kidney disease-associated pruritus’ (CKD-aP) remains a frequent and compromising symptom in patients with advanced or end-stage renal disease.
(2015) 87, 685–691
In CKD-aP patients, modulating the gut microbiota is a
key for effective management of bothersome Pruritus
Reduces IL6, TNF alpha.
Improves CVD Morbidity risk factors.
Improves Nutritional Status.
Improves QOL-General health improvement seen in 78% patients
(QOL - SF 36 KDoQI).
Sachets or as recommended by the Physician
Empty 1 gm sachet powder into
ml of normal water or can be taken directly
minutes before Meal. (Not to be taken with milk or hot water)
International Journal of Basic & Clinical Pharmacology
Dr Sanjay et al, IJBCP | April 2017 | Vol 6 | Issue 4, Page 765
The content of this page is only for the use of a registered medical practitioner or a hospital or a laboratory.